March 2026 | Delivery Insights: RJH Biosciences Contract Services
RJH Biosciences provides polymer-based transfection solutions supporting RNA and DNA delivery across cell lines, primary cells, and in vivo models. This edition highlights recent client
February 2026 | Advancing mRNA Delivery In Vivo: New Animal Study Results
Polymer-Based Solutions for Effective In Vivo mRNA Delivery At RJH Biosciences, we develop non-viral, polymer-based delivery platforms engineered for efficient and reproducible mRNA delivery across
January 2026 | Polymer-Based Solutions for Strong RNA and DNA Delivery Across Biological Systems
At RJH Biosciences, we develop non-viral, polymer-based transfection technologies optimized for delivery of nucleic acids across a wide range of modalities. Our platforms enable efficient
December 2025 | CRISP-Fect: A Polymer-Based Platform for Efficient CRISPR Genome Editing
Learn how our polymer-based transfection reagents enable CRISPR activity and open new possibilities for gene editing. Engineered for high-efficiency gene editing. GFP Knockout CRISP-Fect: Functional Knockout Validated
October 2025 | Proven In Vivo Performance for mRNA and siRNA Delivery
Strong mRNA expression and siRNA silencing across multiple organs demonstrate the superior performance and reliability of RJH’s delivery technology. Robust Multi-Organ mRNA Expression mRNA-Fect Ultra
September 2025 | mRNA Delivery to Drive PBMC Functionality
Efficient delivery leads to protein expression and functional outcomes from primary human blood cells. Effective mRNA Delivery to PBMCs PBMCs were transfected with GFP mRNA